The Court of Appeal partially reversed the Brussels Commercial Court’s decision invalidating Lundbeck’s SPC for escitalopram, to the extent that it had immediate effect.

A summary of this case will be posted on http://www.KluwerIPCases.com

 


_____________________________

Kluwer IP Law
This page as PDF